BRACCO DIAGNOSTICS INC FDA Inspection Record
BRACCO DIAGNOSTICS INC is an FDA-registered facility (FEI 1000307800) located in Princeton, NJ, US. Registered operations: MANUFACTURE. RegDataLab tracks 7 FDA inspections and 1 compliance action at this facility.
What FDA found at this site
- Latest inspection
- Nov 27, 2024: Voluntary Action Indicated (VAI)
- Inspections on record
- 7 (1 OAI, 6 VAI)
- Last OAI inspection
- Jun 13, 2013
- Warning letters
- 1 listed by FDA for this FEI, latest Jan 31, 2012
- Recalls as the recalling firm
- 15, latest Mar 8, 2018
Inspections and what FDA cited
| Date | Result | What FDA cited |
|---|---|---|
| Nov 27, 2024 | Voluntary Action Indicated (VAI) | Failure to develop written procedures (21 CFR 314.80(b)) Late submission of 15-day report (21 CFR 314.80(c)(1)(i)) |
| Jun 5, 2017 | Voluntary Action Indicated (VAI) | Late submission of 15-day report (21 CFR 314.80(c)(1)(i)) |
| May 30, 2014 | Voluntary Action Indicated (VAI) | Written control procedures (21 CFR 212.50(a)) Failure to develop written procedures (21 CFR 314.80(b)) |
| Jun 13, 2013 | Official Action Indicated (OAI) | Procedures not in writing, fully followed (21 CFR 211.22(d)) input/output verification (21 CFR 211.68(b)) Written QA procedures established, followed (21 CFR 212.20(e)) Written specifications - components (21 CFR 212.40(b)) and 2 more |
| Jul 27, 2012 | Voluntary Action Indicated (VAI) | Procedures not in writing, fully followed (21 CFR 211.22(d)) Computer control of master formula records (21 CFR 211.68(b)) Lack of or inadequate complaint procedures (21 CFR 820.198(a)) Written QA procedures established, followed (21 CFR 212.20(e)) and 6 more |
| Mar 8, 2012 | Voluntary Action Indicated (VAI) | Investigator non-compliance (21 CFR 312.56(b)) Records of receipt, shipment, disposition (21 CFR 312.57(a)) General responsibilities of sponsors (21 CFR 312.50) Notification of FDA of termination of investigator (21 CFR 312.56(b)) |
| Jul 11, 2011 | Voluntary Action Indicated (VAI) | No citations listed |
Recalls
| Date | Class | Recall | Product and reason |
|---|---|---|---|
| Mar 8, 2018 | Class II | D-0609-2018 | E-Z-Paste Barium Sulfate Esophageal Cream (60% w/w),
454 g tube, Rx only, Manufactured by… Failed stability specifications: Out-of-specification (OOS) result for a preservative assay - methylparaben - during stability testing of… |
| May 27, 2015 | Class III | D-1147-2015 | E-Z-CAT Dry Barium Sulfate for Suspension (2% w/w after mixing), 23 g foil pouches, Rx… Failed stability specifications:This recall has been initiated due to out of specification results for viscosity. |
| Sep 18, 2014 | Class III | D-0014-2015 | E-Z- GAS II EFFERVESCENT GRANULES Antacid/Antiflatulent ,4 g (0.14 oz), 50 -count box, Rx… Subpotent Drug: Out of Specification (OOS) result during routine stability testing at 24 months. |
| Jul 2, 2014 | Class III | D-1536-2014 | E-Z-HD (barium sulfate) For Suspension (98% w/w), 340 g bottle, Rx Only, Manufactured by… Subpotent Drug: Low out of specification results for both pH and assay obtained during routine stability testing after 36 months. |
| Dec 16, 2013 | Class III | D-1083-2014 | VoLumen Barium Sulfate Suspension (0.1 % w/v, 0.1 ww/w), 450 mL bottle, Rx Only… Failed Stability Testing: This product is below specification for preservative content. |
| Jul 19, 2013 | Class III | D-914-2013 | Tagitol V Barium Sulfate Suspension (40% w/v, 30% w/w) Net Contents: 20 mL, (NDC… Failed Stability Specifications: Tagitol V Barium Sulfate Lot #65846 sampled at 10 months exhibited results above the upper specification… |
| Jun 21, 2013 | Class II | D-885-2013 | Gastrografin (Diatrizoate Meglumine and Diatrizoate Sodium Solution), USP, 37% Organically… Presence of foreign substance: One lot of the product may contain black foreign particles |
| Nov 21, 2012 | Class I | D-157-2013 | Isovue -370 (Iopamidol) Injection 76%, Prefilled 10 x 75 mL (NDC 0270-1316-66), 10 x 100… and 1 more product Presence of Particulate Matter; fibers identified as cellulose and polyvinyl |
| Aug 14, 2012 | Class III | D-095-2013 | Choletec - Kit for the Preparation of Technetium Tc 99m Mebrofenin, 10 vials per box… Presence of Particulate Matter; potential for charcoal particulates |
| Jun 1, 2012 | Class II | D-1684-2012 | CARDIOGEN-82 (Rubidium Rb 82 Generator), 140 millicurie, Rx Only, For Elution of sterile… GMP deviation; Sr-82 levels exceeded alert limit specification |
FDA record score
9 of 100. A count of this site's adverse public FDA records, weighted by how recent each one is. A higher number means more, or more recent, records. Each record below adds the points shown.
16 records behind this number
| Record | Date | Points x age weight | Adds |
|---|---|---|---|
| Inspection classified VAI | Nov 27, 2024 | 6 x 1 | 6 |
| Inspection classified VAI | Jun 5, 2017 | 6 x 0.25 | 1.5 |
| Class II recall D-0609-2018, this FEI as the recalling firm | Mar 8, 2018 | 4 x 0.25 | 1 |
| Inspection classified VAI | May 30, 2014 | 10 years or older, so it adds no points | 0 |
| Class II recall D-885-2013, this FEI as the recalling firm | Jun 21, 2013 | 10 years or older, so it adds no points | 0 |
| Inspection classified OAI | Jun 13, 2013 | 10 years or older, so it adds no points | 0 |
| Class I recall D-157-2013, this FEI as the recalling firm | Nov 21, 2012 | 10 years or older, so it adds no points | 0 |
| Inspection classified VAI | Jul 27, 2012 | 10 years or older, so it adds no points | 0 |
| Class II recall D-1684-2012, this FEI as the recalling firm | Jun 1, 2012 | 10 years or older, so it adds no points | 0 |
| Class II recall D-1665-2012, this FEI as the recalling firm | Apr 16, 2012 | 10 years or older, so it adds no points | 0 |
| Inspection classified VAI | Mar 8, 2012 | 10 years or older, so it adds no points | 0 |
| Warning letter on FDA's dashboard, which does not show close-outs | Jan 31, 2012 | 10 years or older, so it adds no points | 0 |
| Class II recall D-1115-2012, this FEI as the recalling firm | Sep 20, 2011 | 10 years or older, so it adds no points | 0 |
| Class II recall D-866-2011, this FEI as the recalling firm | Jul 29, 2011 | 10 years or older, so it adds no points | 0 |
| Inspection classified VAI | Jul 11, 2011 | 10 years or older, so it adds no points | 0 |
| Class II recall D-033-4, this FEI as the recalling firm | Aug 7, 2003 | 10 years or older, so it adds no points | 0 |
When each source was last refreshed
| Records | Last refreshed | Source as of | Status |
|---|---|---|---|
| Inspections | Nov 16, 2026 | Newest record Nov 5, 2026 | Current |
| Inspection citations | Nov 16, 2026 | Newest record Nov 5, 2026 | Current |
| Compliance actions (warning letters, injunctions and other action types) | Nov 2, 2026 | Newest record Oct 29, 2026 | Current |
| Warning letter text | Nov 16, 2026 | Newest record Nov 10, 2026 | Current |
| Recalls (Enforcement Report) | Nov 16, 2026 | Newest record Nov 11, 2026 | Current |
| Form 483s and inspection documents | Nov 13, 2026 | Newest record Nov 12, 2026 | Current |
| Import refusals | Nov 15, 2026 | Newest record Nov 5, 2026 | Current |
Reviewing BRACCO DIAGNOSTICS INC as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.
Or check BRACCO DIAGNOSTICS INC yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.
Facility details
- Company
- Bracco Diagnostics, Inc.
- Location
- Princeton, NJ (US)
- Registration Expires
- Dec 31, 2027
- Operations
- MANUFACTURE
- Source
- decrs